Skip to main content

Advertisement

Table 4 Patients with idiopathic diabetes divided in groups A (patients who continued insulin after 12 months from the disease onset) and B (patients who suspended insulin after 12 months from the disease onset)

From: Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis

  Group A (N = 12) Group B (N = 18) p*
Mean ± SD Mean ± SD
Clinical parameters
 Age of onset 31.3 ± 7.31 26.8 ± 10.7 0.220
 BMI (kg/m2) 25.7 ± 3.01 24.9 ± 3.31 0.529
 WC (cm) 97.4 ± 11.3 97.3 ± 9.8 0.994
 SBP (mmHg) 112.9 ± 14.9 112.6 ± 8.83 0.953
 DBP (mmHg) 69.6 ± 9.14 67 ± 9.84 0.461
 VAI 1.09 ± 0.22 1.71 ± 0.34 < 0.001
Metabolic parameters
 HDL-cholesterol (mmol/l) 1.01 ± 0.31 0.98 ± 0.08 0.540
 Triglycerides (mmol/l) 0.77 ± 0.11 0.98 ± 0.27 0.017
 LDL-cholesterol (mmol/l) 3.41 ± 0.67 3.52 ± 0.81 0.689
 Total-cholesterol (mmol/l) 4.78 ± 0.67 4.96 ± 0.85 0.529
 GOT (U/l) 25.5 ± 10.4 19.8 ± 6.60 0.082
 GPT (U/l) 25.9 ± 9.63 19.3 ± 9.35 0.075
 Glycaemia (mmol/l) 7.47 ± 0.90 6.95 ± 1.01 0.156
 HbA1c (%) 8.01 ± 1.26 8.56 ± 1.09 0.216
 Insulin requirement (U/kg) 0.57 ± 0.10 0.46 ± 0.22 0.129
Insulin Sensitivity Index
 M value 3.4 ± 1.03 2.63 ± 1.12 0.071
  1. p comparison between means in patients with idiopathic type 1 diabetes, groups A and B